These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Antipyrine metabolism during hepatic regeneration in the rat. Poulsen HE, Pilsgaard H. Liver; 1985 Aug; 5(4):196-9. PubMed ID: 4058271 [Abstract] [Full Text] [Related]
6. Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis. Teunissen MW, Spoelstra P, Koch CW, Weeda B, van Duyn W, Janssens AR, Breimer DD. Br J Clin Pharmacol; 1984 Nov; 18(5):707-15. PubMed ID: 6508980 [Abstract] [Full Text] [Related]
18. Diltiazem treatment impairs hepatic drug oxidation: studies of antipyrine. Carrum G, Egan JM, Abernethy DR. Clin Pharmacol Ther; 1986 Aug; 40(2):140-3. PubMed ID: 3731677 [Abstract] [Full Text] [Related]
19. Antipyrine clearance and metabolite excretion in patients with chronic hepatitis C. Ali HA, el-Yazigi A, Sieck JO, Ali MA, Raines DA, Saour J, Ernst P, Khan B, Døssing M. J Hepatol; 1995 Jan; 22(1):17-21. PubMed ID: 7751582 [Abstract] [Full Text] [Related]
20. Antipyrine metabolism in patients with liver metastases from colorectal cancer. Grieco A, Barone C, Coletta P, Castellano R, Ragazzoni E, Cassano A, Astone A, Gambassi G. Cancer; 1992 Sep 15; 70(6):1477-82. PubMed ID: 1515999 [Abstract] [Full Text] [Related] Page: [Next] [New Search]